Basic Information
Basic information for SOX2-OT-225-57aa
Peptide Name SOX2-OT-225-57aa
Genome Position chr3:181699721-181699883,181739569-181739576[+]
Species Human
Peptide Sequence MKDERGTASSFNWFCPVRSDQAWADKRLREPSRSFAFLPANQTATRQHPDLAWTYPT
Peptide Length 57
Unique No (SOX2-OT-208-57aa,SOX2-OT-212-57aa,SOX2-OT-215-57aa,SOX2-OT-260-57aa,SOX2-OT-285-57aa,SOX2-OT-291-57aa,SOX2-OT-297-57aa,SOX2-OT-298-57aa)
Grand Average of Hydropathicity -0.9228
Relative Molecular Mass 7653.33
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000596250;SOX2-OT-225
Transcript Length 3985
Coding Ability 0.2816
DNA Sequence Corresponding to Peptide ATGAAGGACGAGAGGGGAACTGCAAGCTCCTTCAACTGGTTCTGTCCGGTGAGAAGTGATCAAGCTTGGGCTGACAAGAGGCTCAGGGAGCCCTCACGTTCTTTCGCTTTTTTACCTGCCAATCAAACTGCTACAAGACAACACCCTGATCTGGCATGGACATATCCAACT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :